CryoPort (NASDAQ:CYRX – Get Free Report) and TFI International (NYSE:TFII – Get Free Report) are both transportation companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.
Earnings & Valuation
This table compares CryoPort and TFI International”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CryoPort | $176.18 million | 2.25 | $78.30 million | $1.32 | 6.02 |
| TFI International | $7.88 billion | 1.09 | $310.55 million | $3.72 | 28.00 |
Profitability
This table compares CryoPort and TFI International’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CryoPort | 42.35% | -8.22% | -4.84% |
| TFI International | 3.94% | 13.73% | 5.04% |
Risk and Volatility
CryoPort has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500. Comparatively, TFI International has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500.
Insider and Institutional Ownership
92.9% of CryoPort shares are held by institutional investors. Comparatively, 73.3% of TFI International shares are held by institutional investors. 10.0% of CryoPort shares are held by company insiders. Comparatively, 5.5% of TFI International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and target prices for CryoPort and TFI International, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CryoPort | 1 | 1 | 8 | 0 | 2.70 |
| TFI International | 1 | 8 | 10 | 0 | 2.47 |
CryoPort currently has a consensus price target of $12.94, suggesting a potential upside of 63.03%. TFI International has a consensus price target of $127.75, suggesting a potential upside of 22.66%. Given CryoPort’s stronger consensus rating and higher possible upside, equities analysts plainly believe CryoPort is more favorable than TFI International.
About CryoPort
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
About TFI International
TFI International Inc., together with its subsidiaries, provides transportation and logistics services in the United States and Canada. The company operates through Package and Courier, Less-Than-Truckload (LTL), Truckload (TL), and Logistics segments. The Package and Courier segment engages in the pickup, transport, and delivery of items in North America. The LTL segment is involved in the pickup, consolidation, transportation, and delivery of smaller loads. The TL segment offers expedited transportation, flatbed, tank, container, and dedicated services. This segment also carries full loads directly from the customer to the destination using a closed van or specialized equipment. The Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. As of December 31, 2023, it operates 11,455 trucks, 34,599 trailers, and 7,504 independent contractors. The company was formerly known as TransForce Inc. and changed its name to TFI International Inc. in December 2016. TFI International Inc. was founded in 1957 and is headquartered in Saint-Laurent, Canada.
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.
